Trump told Pfizer CEO price hikes hurt his drug plan, source says

CNBC News

11 July 2018 - Trump rolled out a plan in May on how his administration will lower drug prices.

U.S. President Donald Trump called Pfizer Chief Executive Ian Read on Tuesday to say the company's July 1 price hikes had complicated the administration's drug pricing plans, prompting the company to defer its planned increases, according to a source familiar with the matter.

Pfizer said on Tuesday it was deferring its drug price increases on around 40 drugs for no more than six months after Read's conversation with Trump.

U.S. Health and Human Services secretary Alex Azar called Read previously, and the Pfizer CEO asked to speak directly with the president, the source said.

Read CNBC News article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Pricing